HR Path strengthens its North American Dayforce practice through its merger with Enforce
PARIS, Jan. 20, 2026 /PRNewswire/ -- HR Path, a global leader in…
GracoRoberts Acquires Sky Mart to Accelerate Latin American Expansion, Anchored by Miami Hub
Transaction Enhances MRO Scale, AOG Readiness, and Lubricants Market LeadershipARLINGTON, Texas, Jan. 15, 2026…
Geotab Receives Frost & Sullivan’s 2025 North American Company of the Year Recognition for Excellence in Commercial Vehicle Fleet Management Leadership
Recognized for market leadership, innovation, and customer-centric fleet management and telematics solutions…
NORTH AMERICAN AND EUROPEAN MANUFACTURERS’ PURCHASING DECLINES AGAIN IN DECEMBER, SIGNALING SLOWER CONDITIONS HEADING INTO 2026: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
Ongoing weakness in North American and European factory purchasing points to a…
Hughes Network Systems Receives Frost & Sullivan’s 2025 North American Managed SD-WAN Services Customer Value Leadership Recognition for Excellence in Secure Hybrid Connectivity
The company is honored for delivering superior customer purchase and ownership experiences…
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
IRVINE, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON”…
DirectH2 Inc., an American startup founded and led by Indian entrepreneurs, signs Letter of Intent with Shree Tuljabhavani Sugar Private Limited (STSPL), Maharashtra, India to collaborate on India business development and early funding
DALLAS, Dec. 16, 2025 /PRNewswire/ -- The U.S. Start-up, DirectH2 Inc. led…
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
December 11, 2025 18:22 ET | Source: Mesoblast Limited NEW YORK, Dec.…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear…
